BR0211400A - Tratamento de distrofia muscular com células de sangue do cordão - Google Patents

Tratamento de distrofia muscular com células de sangue do cordão

Info

Publication number
BR0211400A
BR0211400A BR0211400-3A BR0211400A BR0211400A BR 0211400 A BR0211400 A BR 0211400A BR 0211400 A BR0211400 A BR 0211400A BR 0211400 A BR0211400 A BR 0211400A
Authority
BR
Brazil
Prior art keywords
treatment
cord blood
muscular dystrophy
blood cell
cell muscular
Prior art date
Application number
BR0211400-3A
Other languages
English (en)
Inventor
Robert H Brown
Seth P Finklestein
Original Assignee
Viacell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viacell Inc filed Critical Viacell Inc
Publication of BR0211400A publication Critical patent/BR0211400A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TRATAMENTO DE DISTROFIA MUSCULAR COM CéLULAS DE SANGUE DO CORDãO". A presente invenção refere-se a métodos para tratar um paciente sofrendo de distrofia muscular por administração de células de sangue de cordão umbilical, por exemplo, por infusão IV.
BR0211400-3A 2001-07-23 2002-07-23 Tratamento de distrofia muscular com células de sangue do cordão BR0211400A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30722701P 2001-07-23 2001-07-23
PCT/US2002/023368 WO2003009857A1 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Publications (1)

Publication Number Publication Date
BR0211400A true BR0211400A (pt) 2004-11-09

Family

ID=23188804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211400-3A BR0211400A (pt) 2001-07-23 2002-07-23 Tratamento de distrofia muscular com células de sangue do cordão

Country Status (10)

Country Link
US (2) US7452529B2 (pt)
EP (1) EP1411957A1 (pt)
JP (1) JP2004536139A (pt)
CN (1) CN1638783A (pt)
BR (1) BR0211400A (pt)
CA (1) CA2455726A1 (pt)
HU (1) HUP0501108A3 (pt)
IL (1) IL160030A0 (pt)
PL (1) PL367979A1 (pt)
WO (1) WO2003009857A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
WO2005120526A1 (ja) * 2004-06-11 2005-12-22 Combi Corporation 筋ジストロフィー進行抑制組成物
US20100291042A1 (en) 2007-05-03 2010-11-18 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN104212760B (zh) 2013-05-29 2017-08-08 中国科学院上海生命科学研究院 肌肉干细胞体外培养方法及其应用
JP6401445B2 (ja) * 2013-10-10 2018-10-10 国立大学法人 東京大学 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法
CN105793411B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
CN107920503A (zh) 2015-06-11 2018-04-17 伊利诺伊大学理事会 肌营养不良症嵌合细胞和治疗肌营养不良症的方法
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
CA2311729A1 (en) * 1998-01-23 1999-07-29 Imclone Systems Incorporated Purified populations of stem cells
US20020051762A1 (en) 1998-01-23 2002-05-02 Shahin Rafii Purified populations of endothelial progenitor cells

Also Published As

Publication number Publication date
CA2455726A1 (en) 2003-02-06
PL367979A1 (en) 2005-03-21
IL160030A0 (en) 2004-06-20
EP1411957A1 (en) 2004-04-28
US20090068156A1 (en) 2009-03-12
US7452529B2 (en) 2008-11-18
HUP0501108A2 (en) 2006-04-28
CN1638783A (zh) 2005-07-13
HUP0501108A3 (en) 2006-11-28
US20030118565A1 (en) 2003-06-26
WO2003009857A8 (en) 2003-12-24
JP2004536139A (ja) 2004-12-02
WO2003009857A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
BR0211400A (pt) Tratamento de distrofia muscular com células de sangue do cordão
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
TW200503674A (en) Therapeutic agents
NO20033617L (no) Fremgangsmate for behandling av diabetes mellitus
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
ATE490470T1 (de) Therapieverfahren
BR0315630A (pt) Administração de combinação de uma indolinona com um agente quimioterapêutico para distúrbios de proliferação celular
BRPI0407427A (pt) Método para tratar um paciente e para tratar a mielodisplasia
CA2502394A1 (en) Surgical articles
DK0975595T3 (da) Kokainanaloger
DK1750716T3 (da) Behandling af T-celle-lymfom under anvendelse af 10-propargyl-10-deazaaminopterin
BRPI0804623A2 (pt) uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
SE0102147D0 (sv) New methods
NO20051390L (no) Fremgangsmate for behandling av pasienter med massivt blodtap
EA202090558A1 (ru) Схемы лечения
ATE372774T1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
DE502004002171D1 (de) Verwendung von 2-amino-2h-chinazolin-derivaten zur herstellung von therapeutischen mitteln
WO2002094199A3 (en) METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
CY1116171T1 (el) Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις
MXPA03011004A (es) Derivados de fenilalquiloxi-fenilo novedosos.
ATE296814T1 (de) Ionenkanal modulierende mittel
TW200503999A (en) Therapeutic agents
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]